These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24040908)

  • 41. [Editorial: Pharmazie in unserer Zeit 5/2011].
    Schubert-Zsilavecz M; Högger P
    Pharm Unserer Zeit; 2011 Sep; 40(5):371. PubMed ID: 22083877
    [No Abstract]   [Full Text] [Related]  

  • 42. [Medical treatment of COPD].
    Vestbo J; Titlestad IL
    Ugeskr Laeger; 2013 Apr; 175(18):1261-4. PubMed ID: 23651802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Olodaterol (Striverdi Respimat). COPD: just another beta-2 agonist.
    Prescrire Int; 2016 Apr; 25(170):95. PubMed ID: 27186621
    [No Abstract]   [Full Text] [Related]  

  • 44. Can β2-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD?
    Zhang WH; Zhang Y; Cui YY; Rong WF; Cambier C; Devillier P; Bureau F; Advenier C; Gustin P
    Fundam Clin Pharmacol; 2012 Feb; 26(1):118-34. PubMed ID: 22044554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Albuterol and levalbuterol use and spending in Medicare beneficiaries with chronic obstructive pulmonary disease.
    Puig A; McElligott S; Bergquist H; Doshi JA
    Am J Geriatr Pharmacother; 2010 Dec; 8(6):571-82. PubMed ID: 21356506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacology and therapeutics of bronchodilators.
    Cazzola M; Page CP; Calzetta L; Matera MG
    Pharmacol Rev; 2012 Jul; 64(3):450-504. PubMed ID: 22611179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. (R)-salbutamol in the treatment of asthma and chronic obstructive airways disease.
    Patel M; Thomson NC
    Expert Opin Pharmacother; 2011 May; 12(7):1133-41. PubMed ID: 21453221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.
    Moulton BC; Fryer AD
    Br J Pharmacol; 2011 May; 163(1):44-52. PubMed ID: 21198547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Busch-Petersen J; Lainé DI
    Future Med Chem; 2011 Oct; 3(13):1623-34. PubMed ID: 21942252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of ipratropium bromide on airway and pulmonary muscarinic receptors in a rat model of chronic obstructive pulmonary disease.
    Yao W; Wang G; Zhu H; Sun Y; Zhao M
    Chin Med J (Engl); 2001 Jan; 114(1):80-3. PubMed ID: 11779443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Indacaterol (Onbrez Breezhaler), oral inhalation].
    Duh D; Tanret I
    J Pharm Belg; 2011 Dec; (4):127-8. PubMed ID: 22299240
    [No Abstract]   [Full Text] [Related]  

  • 53. The COPD Pipeline XIII.
    Gross NJ
    COPD; 2011 Dec; 8(6):464-5. PubMed ID: 22149408
    [No Abstract]   [Full Text] [Related]  

  • 54. The COPD pipeline IV.
    Gross NJ
    COPD; 2010 Jun; 7(3):229-31. PubMed ID: 20486822
    [No Abstract]   [Full Text] [Related]  

  • 55. The discovery of AZD9164, a novel muscarinic M3 antagonist.
    Mete A; Bowers K; Chevalier E; Donald DK; Edwards H; Escott KJ; Ford R; Grime K; Millichip I; Teobald B; Russell V
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7440-6. PubMed ID: 22047691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indacaterol.
    Donohue JF; Martinez FJ
    COPD; 2011 Oct; 8(5):327-8. PubMed ID: 21936681
    [No Abstract]   [Full Text] [Related]  

  • 57. The COPD Pipeline XVII.
    Gross N
    COPD; 2012 Aug; 9(4):432-4. PubMed ID: 22734623
    [No Abstract]   [Full Text] [Related]  

  • 58. Limitations of model based dose selection for indacaterol in patients with chronic obstructive pulmonary disease.
    Wang Y; Lee JY; Michele T; Chowdhury BA; Gobburu JV
    Int J Clin Pharmacol Ther; 2012 Sep; 50(9):622-30. PubMed ID: 22578206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacological therapy of chronic obstructive pulmonary disease].
    Montuschi P
    Ann Ist Super Sanita; 2003; 39(4):557-72. PubMed ID: 15098576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-life use of long-acting antimuscarinic agents following their approval for COPD treatment.
    Roche N; Jebrak G; Caillaud D; Deslée G; Brinchault G; Chanez P; Court-Fortune I; Escamilla R; Nesme-Meyer P; Pinet C; Carré P; Paillasseur JL; Perez T; Burgel PR;
    Eur Respir J; 2015 Jan; 45(1):260-2. PubMed ID: 25359339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.